EKB Journal Management System
Keywords = Empagliflozin
Number of Articles: 10
1

Empagliflozin Mitigates Ischemia/Reperfusion-induced Liver Injury in Rats: Modulation of NF-κB, SMAD-4, VEGF, and Fibrinogen Protein Expressions

Articles in Press, Accepted Manuscript , Available Online from 30 October 2023
DeiaaEldeen Elsayed Abouzed; Heba Mohsen Mahmoud; Amira Murad; Ramadan Hemada Hemada
2

Stability Indicating Assay Method of Metformin, Linagliptin and Empagliflozinin Pharmaceutical Dosage Form by HPLC Method

Volume 67, Issue 7, July 2024, Page 443-449
Alaa S Amin; Soha F Mohamed; Mourad Mohamed Abo-Taleb
3

Empagliflozin protects against indomethacin plus pyloric ligation-induced peptic ulcer in rats

Volume 3, Issue 1, January 2024, Page 899-919
Mohammed E. Abo El-Fetoh; Esalm Hassan; Amira Fayed; Laila A Ramadan
4

A Comparative Histological and Immunohistochemical Study on the Possible Therapeutic Effects of Empagliflozin and platelet-rich plasma Against Cisplatin Induced Cardiotoxicity in Rats

Volume 46, Issue 1, March 2023, Page 378-493
Asmaa Ahmed El-Shafei; Rokia Mohamad Hassan; Sara Adel Hosny
5

Mini review on different analytical methods for quantitative determination of linagliptin and empagliflozin either in biological sample or in the pharmaceutical dosage forms

Volume 2, Issue 1, January 2023, Page 110-120
Israa M. Nour; Mohamed Badrawy; Ahmed R. Mohamed
6

Signaling pathways in cardiac fibrosis; A review and future therapeutic options

Volume 7, Issue 3, January 2023, Page 165-180
Mohammed Elsayed; Yasser M. Moustafa; Eman T. Mehanna; Norhan M. El-Sayed; Reem M. Hazem
7

The Potential Anti-ulcerogenic Effects of Baicalein and/or Empagliflozin in Induced Gastric Ulcer in Rats: Modulating HO-1/SIRT1 / HMGB1 signaling Pathway

Volume 42, Issue 3, July 2022, Page 246-264
Elham Nasif; Rania Shalaby; Sarah Ragab Abd El -Khalik; Rash Abd Ellatif
8

A DIHYDROCHALCONE AND SGLT2 INHIBITOR ABATE METHOTREXATE HEPATOTOXICITY IN MALE RATS; A COMPARATIVE STUDY

Volume 65, Issue 1, March and April 2022, Page 206-228
Adel Osman
9

Potential mechanisms underlying the renoprotective effect of empagliflozin, a novel selective sodium glucose co-transporter (SGLT) 2 inhibitor, against diabetic nephropathy in streptozotocin induced diabetic rats

Volume 41, Issue 3, July 2021, Page 344-357
Mona AbdelAzim Said; Hend A. Abdallah
10

Effect of the combination between empagliflozin and calcipotriol on cadmium-induced testicular toxicity in rats

Volume 40, Issue 1, January 2020, Page 15-31
hany mohammad borg; Ahmed Kabel; Remon Estfanous; Maaly Abd Elmaaboud